Carmot Therapeutics' Grant

Carmot Therapeutics raised a round of funding on January 20, 2010. Investors include National Science Foundation.

Carmot Therapeutics is applying its technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to ide…

Articles about Carmot Therapeutics' Grant: